Themis Medicare profit and loss

Latest FY26

Revenue: ₹342cr−15.6% on FY25
EBITDA: ₹0.4cr−99.2% on FY25
Net profit: ₹1.1cr−96.2% on FY25
EPS: ₹0.12−96.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	332	342	406	382	354	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	9.2	9.4	4.7	4.8	11.5
	341	352	410	387	366
	62.5	57.3	76.3	84.7	96.0
	91.1	63.0	73.7	53.6	30.1
	−18.6	9.2	−18.0	−1.6	−7.8
	90.9	93.5	96.4	82.4	66.1
	11.2	10.7	10.0	9.4	9.6
	10.3	10.3	9.9	12.2	10.5
	148	119	128	111	102
	395	363	376	352	307
	−41.9	0.4	49.0	51.5	67.5
	−52.3	−9.9	39.1	39.3	57.0
Profit
	−54.3	−11.3	33.7	34.6	58.9
	92.1	−0.9	0.0	0.0	0.0
	37.8	−12.1	33.7	34.6	58.9
	8.3	0.0	8.3	9.2	15.0
	6.4	0.8	1.5	0.7	0.6
	14.6	0.8	9.8	9.9	15.6
	16.8	14.0	5.9	18.8	13.6
	40.0	1.1	29.8	43.5	56.9
	23.2	−12.9	23.9	24.7	43.3
	−0.8	−0.7	−0.3	−0.7	−0.4
	39.1	0.5	29.5	42.8	56.5
	40.0	1.1	29.8	43.5	56.9
	−0.0	−0.0	−0.0	−0.0	−0.0
Per share
	₹4.34	₹0.12	₹3.24	₹4.73	₹61.83
	₹4.33	₹0.12	₹3.24	₹4.72	₹61.73
Other comprehensive income — detail
	−0.8	−0.7	−0.3	—	—
	−1.1	−1.0	−0.4	−1.0	−0.6
	−0.3	−0.3	−0.1	—	—
	—	—	—	−0.2	−0.1
	—	—	0.0	0.0	−0.0
	39.1	—	29.5	42.8	—
	−0.0	—	−0.0	−0.0	—
Per share — as-filed variants
	₹4.34	₹0.12	₹3.24	₹4.73	₹61.83
	₹4.33	₹0.12	₹3.24	₹4.72	₹61.73
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	197	213	274	245	236
	59.3%	62.2%	67.5%	64.2%	66.6%
Adjusted (ex-exceptional items) — derived
	−54.3	−11.3	33.7	34.6	58.9
	92.1	−0.9	0.0	0.0	0.0
	−16.5	2.0	29.8	43.5	56.9
	−₹1.79	₹0.21	₹3.24	₹4.73	₹61.83

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THEMISMED₹98.44

Themis Medicare Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersLINCOLN BAJAJHCARE SIGACHI WANBURY AMRUTANJAN AHCLANUHPHRMcap ₹907 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	354.3	381.8	405.5	342.2	331.6
Other Income	11.5	4.8	4.7	9.4	9.2
Total Income	365.8	386.5	410.2	351.6	340.8
Expenses
+ Cost of Materials Consumed	96.0	84.7	76.3	57.3	62.5
+ Purchases of Stock-in-Trade	30.1	53.6	73.7	63.0	91.1
+ Changes in Inventories	-7.8	-1.6	-18.0	9.2	-18.6
+ Employee Benefit Expense	66.1	82.4	96.4	93.5	90.9
+ Finance Costs	9.6	9.4	10.0	10.7	11.2
+ Depreciation & Amortisation	10.5	12.2	9.9	10.3	10.3
+ Other Expenses	102.4	111.1	128.1	118.9	147.7
Total Expenses	306.9	351.9	376.4	362.9	395.1
EBITDA	67.5	51.5	49.0	0.4	-41.9
EBIT	57.0	39.3	39.1	-9.9	-52.3
Profit
PBT before Exceptional Items	58.9	34.6	33.7	-11.3	-54.3
+ Exceptional Items	0.0	0.0	0.0	-0.9	92.1
Pretax Income	58.9	34.6	33.7	-12.1	37.8
+ Current Tax	15.0	9.2	8.3	0.0	8.3
+ Deferred Tax	0.6	0.7	1.5	0.8	6.4
Tax Expense	15.6	9.9	9.8	0.8	14.6
+ Share of Associates & JVs	13.6	18.8	5.9	14.0	16.8
Net Income	56.9	43.5	29.8	1.1	40.0
+ Net Income — Continuing Ops	43.3	24.7	23.9	-12.9	23.2
+ Other Comprehensive Income	-0.4	-0.7	-0.3	-0.7	-0.8
Total Comprehensive Income	56.5	42.8	29.5	0.5	39.1
Net Income to Common	56.9	43.5	29.8	1.1	40.0
Minority Interest	-0.0	-0.0	-0.0	-0.0	-0.0
Per Share
Basic EPS	61.83	4.73	3.24	0.12	4.34
Diluted EPS	61.73	4.72	3.24	0.12	4.33
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.3	-0.7	-0.8
+ Items NOT to be Reclassified to P&L	-0.6	-1.0	-0.4	-1.0	-1.1
+ Tax on Items NOT to be Reclassified	—	—	-0.1	-0.3	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.2	—	—	—
+ Items to be Reclassified to P&L	-0.0	0.0	0.0	—	—
Comprehensive Income — Owners of Parent	—	42.8	29.5	—	39.1
Comprehensive Income — Non-controlling Interests	—	-0.0	-0.0	—	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	61.83	4.73	3.24	0.12	4.34
Diluted EPS — Continuing Operations	61.73	4.72	3.24	0.12	4.33
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	236.0	245.0	273.5	212.8	196.6
Gross Margin %	66.59	64.19	67.45	62.17	59.27
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	58.9	34.6	33.7	-11.3	-54.3
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-0.9	92.1
Net Income Adj (tax-effected)	56.9	43.5	29.8	2.0	-16.5
EPS Adj	61.83	4.73	3.24	0.21	-1.79
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	9.2	9.2	9.2	9.2	9.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.